Todd Hannigan, the Executive Chairman of IperionX Ltd (NASDAQ:IPX), has executed a series of substantial share acquisitions, reinforcing his direct ownership stake in the company. The transactions involve the purchase of 525,000 ordinary shares, with a combined transaction value of A$1,881,165. These purchases were finalized on July 10 and July 13, 2026, with execution prices averaging between A$3.5786 and A$3.5866 per share. It is important to note that these specific ordinary shares are traded on the Australian Stock Exchange.
These insider transactions take place during a period of significant price depreciation for IPX equity. Over the preceding six-month window, the stock has experienced a decline of approximately 46 percent. At the time of reporting, the shares were trading at $25.03, representing a substantial discount of roughly 59 percent from the 52-week high of $61.45. Market data indicates that the stock has faced recent downward pressure, with reports suggesting a nearly 12 percent fall over the last week. Despite this volatility, analyst sentiment remains constructive, with a Strong Buy consensus maintained and price targets indicating potential for significant upside.
On July 10, Hannigan acquired 225,000 ordinary shares at an average price of A$3.5786. This transaction increased his direct holdings to 26,333,334 shares. Three days later, on July 13, he purchased an additional 300,000 ordinary shares at an average price of A$3.5866, bringing his total direct ownership to 26,633,334 shares. Beyond direct equity, Hannigan holds 454,464 Restricted Stock Units (RSUs). Of these, 159,334 units are scheduled to vest in December 2026, while the remaining 295,130 units are set to vest in April 2028.
His derivative portfolio includes a complex array of performance rights and options. He holds 306,302 performance rights with exercise prices of A$6, A$7, and A$8, respectively, all expiring in April 2030. Additionally, he holds 196,086 performance rights with an exercise price of A$18, expiring in April 2031. His option holdings include 465,410 options with an exercise price of A$18 and 526,760 options with an exercise price of A$22, both expiring in April 2031. Hannigan also holds 50,000 American Depository Shares (ADS) of IperionX Ltd, traded on NASDAQ, where each ADS is convertible into 10 ordinary shares.
Concurrently, IperionX Limited has announced the pricing of a public offering valued at approximately $50 million. This offering consists of 2,275,000 American Depositary Shares priced at $21.98 per ADS, with each ADS representing 10 ordinary shares. The proceeds are calculated prior to deducting underwriting discounts, commissions, and estimated offering expenses. In related market activity, Texas Capital Securities has initiated coverage of IperionX stock with a Buy rating, establishing a price target of $55.00. The firm highlighted the company's strategic focus on developing a titanium supply chain in the United States through vertical integration and proprietary technology.